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Endothelial and hematopoietic lineages
emerge from common progenitors. Here,
Singh et al. identify miR-130a as a direct
target of Etv2 and demonstrate its role in
segregating bipotent hemato-endothelial
progenitors toward the endothelial
lineage. Mechanistically, miR-130a
directly suppresses Pdgfra expression
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MicroRNAs (miRNAs) are known to regulate crit-
ical developmental stages during embryogenesis.
Here, we defined an Etv2-miR-130a cascade that
regulates mesodermal specification and determina-
tion. Ablation of Dicer in the Etv2-expressing pre-
cursors resulted in altered mesodermal lineages
and embryonic lethality. We identified miR-130a as
a direct target of Etv2 and demonstrated its role in
the segregation of bipotent hemato-endothelial pro-
genitors toward the endothelial lineage. Gain-of-
function experiments demonstrated that miR-130a
promoted the endothelial program at the expense
of the cardiac program without impacting the he-
matopoietic lineages. In contrast, CRISPR/Cas9-
mediated knockout of miR-130a demonstrated a
reduction of the endothelial program without
affecting hematopoiesis. Mechanistically, miR-130a
directly suppressed Pdgfra expression and pro-
moted the endothelial program by blocking Pdgfra
signaling. Inhibition or activation of Pdgfra signaling
phenocopied the miR-130a overexpression and
knockout phenotypes, respectively. In summary,
we report the function of a miRNA that specifically
promotes the divergence of the hemato-endothelial
progenitor to the endothelial lineage.INTRODUCTION
During embryogenesis, mesodermal progenitors give rise
to multiple lineages, including hemato-endothelial and cardiac
lineages. For example, Flk1/Pdgfra+ (paraxial mesoderm) and
Flk1+/Pdgfra (lateral plate mesoderm) cells arise from the
Flk1+/Pdgfra+ unpatterned mesoderm (Kataoka et al., 2011;
Sakurai et al., 2006). These lineages respond todistinct transcrip-
tional networks and signaling cues. Precise control of the speci-
fication of these lineages is necessary for proper development
and embryogenesis. The transcriptional regulators and signaling
pathways that govern these mesodermal progenitors are incom-
pletely defined (Kattman et al., 2006; Loebel et al., 2003).CeStudies have established a hierarchy of transcriptional regula-
tors includingMesp1, Vegf/Flk1, and Etv2 asmodulators of hem-
ato-endothelial development (Shalaby et al., 1995; Saga et al.,
1999; Ferdous et al., 2009). Ablation of Etv2 results in embryonic
lethality by embryonic day 9.5 (E9.5) with complete absence of
the hemato-endothelial lineages (Ferdous et al., 2009; Koyano-
Nakagawa et al., 2012). Etv2 serves as a key regulator of hem-
ato-endothelial lineages through its interaction with multiple
factors including Tie2, Lmo2, Gata2, and FoxC2 (De Val et al.,
2008; Rasmussen et al., 2011; Koyano-Nakagawa et al., 2012;
Shi et al., 2014). While the transcriptional hierarchy in hemato-
endothelial development has been well described, the role of
miRNAs in these progenitors are unknown.
MicroRNAs (miRNAs) govern the molecular switch by sup-
pressing gene expression, thereby modulating and fine-tuning
cell fate decisions (Ivey and Srivastava, 2010). Although global
deletion as well as hypomorphic mutants of Dicer (an miRNA-
processing enzyme) results in embryonic lethality (Bernstein
et al., 2003; Yang et al., 2005), it is unclear whether Dicer and
miRNAs play any role in the hemato-endothelial segregation
and vascular develoment.
In the present study, we deciphered the requirement of miRNA
biogenesis in early mesodermal precursors. We discovered an
Etv2-miR-130a-Pdgfra network that directs the hemato-endo-
thelial progenitors toward the endothelial fate without affecting
the hematopoietic lineage. These findings define a factor that
directs endothelial development without affecting the hemato-
poietic lineage.
RESULTS
Etv2-Cre-Mediated Dicer Deletion Results in Altered
Mesodermal Lineages and Embryonic Lethality
Analysis of mesodermal transcripts during embryonic stem cell/
embryoid body (ESC/EB) differentiation indicated that Mesp1
was transiently but robustly expressed at day 3 of differentiation
with subsequent expression of both Flk1 and Etv2 at d4,
marking the appearance of the mesodermal lineages (Fig-
ure S1A). To evaluate the functional role of Dicer (miRNA depen-
dent and independent) in the mesodermal progenitors, we
conditionally deleted floxed-Dicer using Cre recombinase under
the control of Mesp1, Flk1, or Etv2 promoter elements. qPCR
analysis revealed efficient deletion of the Dicer allele from
sorted cells using fluorescence-activated cell sorting (FACS)ll Reports 13, 915–923, November 3, 2015 ª2015 The Authors 915
Figure 1. Etv2 Modulates miR-130a Expression in the Endothelial Progenitors
(A–F) Representative FACS profiles (A and D) and quantification (B, C, E, and F) of mesodermal populations in Etv2-EYFP:Etv2-Cre;DicerL/L embryos at E7.5 from
EYFP+ and EYFP compartments.
(G) qPCR analysis of miR-130a in CD31+ cells sorted from DicerL/L and Etv2-Cre;DicerL/L embryos at E9.5.
(H) Evolutionary conservation of the 5.0 kb upstream fragment of the miR-130a gene.
(legend continued on next page)
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(Figure S1B). Whole-mount analysis revealed embryonic
lethality in Mesp1-Cre;DicerL/L embryos by E10.5, and the
Flk1-Cre;DicerL/L and the Etv2-Cre;DicerL/L embryos were lethal
by E12.5 due to vascular defects (Figure S1C; Table S1). These
results indicated an essential requirement for miRNAs in the
endothelial lineage. Importantly, Tie2-Cre;DicerL/L or VE-Cad-
Cre;DicerL/L conditional mutants were viable with no obvious
vascular defects (Sua´rez et al., 2007). Based on our findings
and these reports, we hypothesized that miRNAs induced
during Flk1 and Etv2 expression are essential for endothelial
development.
Previously, we reported that Etv2 mutants have altered
mesodermal populations (Rasmussen et al., 2011). To evaluate
whether mesodermal derivatives were affected in Etv2-Cre;
DicerL/L mutants, we crossed Etv2-Cre;DicerL/+ and Etv2-EYFP;
DicerL/L lines and undertook FACS analysis at E7.5. The Etv2-
EYFP reporter was used to label the hemato-endothelial lineages
(Rasmussen et al., 2011). We did not observe any change in the
number of EYFP+ cells between DicerL/L and Etv2-Cre;DicerL/L
embryos at E7.5 (Figure S1D). Further, our analysis showed a
significant increase in the number of the Flk1/Pdgfra+ cells in
the EYFP+ compartment of the Dicer conditional mutants (Fig-
ures 1A–1C; Figure S1E) without any change in the Flk1+/Pdgfra+
and Flk1+/Pdgfra populations (Figures S1F and S1G). In
contrast, in the EYFP fractions, no changes in the Flk1/
Pdgfra+ or Flk1+/Pdgfra+ populations were observed (Figures
1D–1F). These results demonstrated that miRNAs expressed
in the Etv2+ progenitors are critical for segregation of the
mesodermal lineages.
To decipher the role of specific miRNA in the endothelial pro-
genitors, we analyzed miRNAs that were enriched in endothelial
lineages. qPCR analysis from sorted CD31+ cells versus CD31
cells in E9.5 embryos revealed robust expression of miR-126,
miR-126*, miR-221, miR-27b, miR-130a, and miR-130b (Fig-
ure S1H). We focused on miR-130a, as relatively little is known
regarding its role during embryogenesis and lineage determi-
nation. To evaluate the role of miR-130a in the regulation of
hemato-endothelial lineages, we FACS sorted Flk1+ cells from
day 4 EBs and observed significant enrichment of miR-130a in
Flk1+ cells relative to Flk1 cells (Figure S1I). Next, to assess
the lineage specific expression of miR-130a in vivo, we sorted
CD31+, CD41+, and cardiac progenitor cells (CPCs; Nkx-2.5-
EYFP+ cells) from E9.5 embryos and detected robust expression
ofmiR-130a in CD31+ cells relative to other lineages (Figure S1J).
These results indicated that miR-130a is enriched in the endo-
thelial progenitors. FACS-sorted CD31+ cells from the Etv2-
Cre;DicerL/L embryos demonstrated reduced expression of
mature miR-130a, indicating that Dicer is required for miR-
130a biogenesis in the Etv2+ lineage (Figure 1G). To define the
regulatory network for miR-130a, we analyzed the 5.0-kb
upstream region of the miR-130a locus and found three highly(I) Top: schematic of the 2.8 kb upstream region of themiR-130a promoter. Botto
antibody. ChIP assay for the Gapdh promoter (Control) and a non-specific locus
(J) EMSA showing Etv2 bound to the Ets binding site in the miR-130a promoter
(K) Luciferase reporter constructs using the miR-130a promoter (1.0 kb) harbo
(L) qPCR analysis of miR-130a using EYFP+ sorted cells from Etv2 wild-type and
Error bars indicate SEM (n = 4; *p < 0.05; **p < 0.005) (see also Figure S1).
Ceconserved binding motifs for Etv2 (Figure 1H). Using chromatin
immunoprecipitation (ChIP) assays and doxycycline (Dox)-
inducible HA-Etv2 cell lysates, we observed a 15-fold enrich-
ment of Etv2 at the cis-regulatory region of the miR-130a
promoter, but not in the non-specific region of the miR-130a lo-
cus, at day 4 of differentiation (Figure 1I). Gel-shift assays further
confirmed that Etv2 could bind to the miR-130a promoter con-
taining the Etv2 recognition sequence (Figure 1J). Transcrip-
tional assays using the 1.0-kb miR-130a promoter-reporter
construct revealed that Etv2 potently transactivated the miR-
130a promoter in a dose-dependent fashion and mutagenesis
of the Etv2 binding motifs resulted in abolishment of the tran-
scriptional activity (Figure 1K). To monitor whether Etv2 could
regulate miR-130a expression in vivo, we FACS sorted the
Etv2-EYFP+ cells from the Etv2 wild-type (Etv2+/+) and null
(Etv2/) embryos at E7.5. qPCR analysis for miR-130a showed
reduced expression of miR-130a in Etv2/ embryos compared
to controls (Figure 1L). These results indicated that miR-130a
was expressed in early endothelial progenitors and that Etv2 is
a direct upstream regulator of miR-130a.
miR-130a Modulates the Endothelial Lineage during
Embryogenesis
qPCR analysis revealed robust (8-fold) and significant expres-
sion of mature miR-130a transcripts by day 4 (hemato-endothe-
lial specification stage) and remained high at d8 (endothelial
maturation stage) of EB differentiation (Figure S2A). To define
the role miR-130a in endothelial progenitors, we generated an
inducible ESC line which overexpresses miR-130a in response
to Dox (miR-130a iES) (Figure 2A). Induction of miR-130a from
day 2 to day 6 resulted in significantly increased expression of
endothelial transcripts includingCD31, Tie2, and Flk1, with no ef-
fect in the key hematopoietic transcripts including CD41, c-kit,
gata1, and Lmo2 (Figure 2B). Further, FACS analysis showed
that the overexpression of miR-130a resulted in an increase of
the endothelial program (CD31+/Tie2+ and CD31+/VE-cadherin
cells) by 3-fold and 2-fold, respectively (Figures 2C and 2D;
Figures S2B and S2C) without any significant changes in the he-
matopoietic lineage (CD41+/CD45+ cells) at day 6 of EB differen-
tiation (Figures 2E and 2F). Colony-forming assays revealed that
the definitive hematopoietic colonies (definitive erythroid [Ery-D],
granulocyte erythrocyte megakaryocyte macrophage [GEMM],
granulocyte macrophage [GM], and macrophage [Mac]) were
not significantly changed between uninduced and Dox-induced
ESC/EBs (Figure S2D). We next evaluated whether the hemo-
genic endothelial lineages were affected in response to miR-
130a induction. Interestingly, we did not observe a significant
change in the percentages of hemogenic endothelial lineages
(CD41+/Tie2+), whereas the endothelial lineages (CD41/Tie2+)
were robustly increased in the presence of Dox (Figures S2E
and S2F). Altogether, these data demonstrated that miR-130am: ChIP analysis of d4 Dox-inducible HA-Etv2 EBs using a hemagglutinin (HA)
(miR-130a 30 UTR region: 30 flank) are shown as controls.
region.
ring wild-type (wt; open box) or mutant (mut; crossed box) Etv2 binding sites.
mutant embryos at E7.5.
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Figure 2. miR-130a Promotes the Endothe-
lial Lineage
(A) Left panel: phase-contrast images of wild-type
E14 (ESCs) and Dox-inducible miR-130a ESC
(miR-130a iES) colonies. Right panel: qPCR
analysis of miR-130a in the absence (Dox) and
presence (+Dox) of Dox.
(B) qPCR analyses for endothelial and hemato-
poietic markers usingDox and +Dox EBs at d6 of
differentiation (ratio shown as +Dox/Dox).
(C–F) FACS profiles (C and E) and quantification (D
and F) of endothelial (Tie2 and CD31, C and D) and
hematopoietic (CD41 and CD45, E and F) markers
in Dox and +Dox conditions.
(G–J) Representative FACS profiles (G and I) and
quantification (H and J) of endothelial (G and H)
and hematopoietic (I and J) markers in WT and
miR130a/ EBs.
(K) Sections of Dox and +Dox miR-130a iESCs/
EBs immunostained with CD31 (red) and cTnT
(green) at day 10 of EB differentiation. Boxed
regions are shown in panels K0 and K00.
(L) Quantitative analysis of cTnT+ EBs in Dox
(n = 123) and +Dox (n = 142) EBs.
(M) Contractility assay using Dox (n = 146)
and +Dox (n = 135) EBs.
(N) qPCR analyses of a cardiac marker (cTnT)
from Dox and +Dox miR-130a iESCs/EBs.
(O) Cardiogenic assay using WT and miR-130a/
embryoid bodies.
Error bars indicate SEM (n = 5; *p < 0.05). Scale
bar, 200 mm, (see also Figure S2).promoted the endothelial lineage with no effect on hematopoie-
sis. To examine the differential effect of miR-130a, we performed
miR-130a antagomir-mediated knockdown assays using ESCs/
EBs (Figure S2G). Knockdown of miR-130a resulted in a robust
increase inMeox2 (a known target ofmiR-130a;ChenandGorski,
2008) expression (Figure S2H). FACS analysis revealed that
knockdown of miR-130a resulted in a significant reduction of
the endothelial lineage (Figures S2I and S2J), whereas the he-
matopoietic lineages were unaffected (Figures S2K and S2L).
To validate these findings, we generated miR-130a knockout
ESC lines (miR-130a/) using clustered regularly interspaced918 Cell Reports 13, 915–923, November 3, 2015 ª2015 The Authorsshort palindromic repeats (CRISPR)/
Cas9 technology (Figures S2M–S2O).
Consistent with the knockdown studies,
the deletion of miR-130a resulted in
reduced endothelial lineage (CD31+/
Tie2+ cells) development (Figures 2G and
2H) without affecting the hematopoietic
lineages (CD41+/CD45+ cells) (Figures 2I
and 2J). These results confirmed the pref-
erential effect of miR-130a on the endo-
thelial development.
We next examined whether miR-130a
induction affects other mesodermal-
derived lineages. Induction of miR-130a
from days 2 to 6 resulted in a significant
reduction of cardiac Troponin (cTnT)expression in day 10 EBs with a corresponding increase of
CD31 expression (Figure 2K). Quantification of cTnT+ EBs and
beating EBs revealed a significant decrease in the cardiogenic
program upon induction of miR-130a (Figures 2L and 2M).
Furthermore, qPCR analysis revealed decreased expression of
cTnT, concurrent with reduced cardiac contractility in the Dox-
induced EBs (Figure 2N). In contrast, miR-130a/ ESCs/EBs
demonstrated increased cardiogenic potential as we observed
increased percentage of beating embryoid bodies (Figure 2O).
These data suggested that miR-130a promoted the endothelial
lineage at the expense of the cardiac program.
miR-130a Targets Pdgfra Expression and Modulates
Mesodermal Lineage Development
To explore the mechanism by which miR-130a modulates endo-
thelial lineage development, we employed three miRNA target
prediction tools including TargetScan 6.2, PicTar, andmiRANDA
to mine common predicted targets. Among the multiple targets,
we identified Pdgfra as a highly conserved target of miR-130a
with a high percentile score using TargetScan 6.2 in both
mouse and zebrafish genomes (data not shown). Multiple
sequence alignment revealed a highly conserved miR-130a
seed-sequence in the Pdgfra 30 UTR region (Figure 3A). To
examinewhethermiR-130a targetsPdgframRNA, we performed
luciferase assays using a PGK promoter-driven luciferase re-
porter (PGK-Luc-Pdgfra-30-UTR) construct. Co-transfection of
the PGK-Luc-Pdgfra-30-UTR reporter with a miR-130a mimic re-
sulted in a statistically significant reduction (40%) of the lucif-
erase activity, whereas co-transfection withmiR-130a antagomir
resulted in enhancement of the luciferase activity, indicating that
endogenous miR-130a could target the Pdgfra mRNA (Fig-
ure 3B). To assess whether miR-130a could target Pdgfra tran-
scripts in vivo, we injected morpholinos against miR-130a
(miR-130a-MO) at the one- to two-cell stage into fertilized zebra-
fish eggs and performed in situ hybridization for pdgfra mRNA.
Our data demonstrated increased expression of pdgfra in the
miR-130a morphants, indicating that miR-130a could suppress
pdgfra expression in vivo (Figure 3C; Figures S3A and S3B). To
further examine its effect on the endothelial lineage, we utilized
an endothelial specific transgenic reporter (Tg(fli1-EGFP)) line
and injected control MO or miR-130a MO into the fertilized
eggs. qPCR analysis from FACS-sorted fli1-EGFP+ cells re-
vealed enrichment of pdgfra transcripts in the miR-130a mor-
phants relative to the control (Figure 3D). These results indicated
that miR-130a could target Pdgfra transcripts in endothelial cells
in vitro and in vivo. We next evaluated whether injection of miR-
130a morpholinos could affect the hemato-endothelial lineage
specification at early somitogenesis stages. Initially, we per-
formed FACS analysis using the fli1-EGFP reporter to quantify
the angioblasts at the eight-somite stage (Shoji et al., 2003).
Our analysis revealed a reduced percentage of EGFP+ popula-
tions in themiR-130aMO relative to control at the 8 somite stage
(Figures S3C and S3D). Next, we examined kdrl expression using
in situ hybridization in control andmiR130amorphants. Our anal-
ysis revealed reduced expression of kdrl transcripts (brackets)
at 14–16 hours post fertilization (hpf) (Figure S3E). These results
indicated that miR-130a modulates endothelial precursors.
Furthermore, qPCR analysis at 14 hpf and 24 hpf revealed
reduction in the levels of the endothelial program (kdrl) without
affecting the hematopoietic program (gata1) (Figures S3F and
S3G). Similar to the observation in miR-130a/ EBs, we found
increased expression of the cardiogenic marker myl2f at 24 hpf
(Figure S3H). Together, these results indicated that miR-130a
modulates endothelial lineages both in vitro and in vivo.
Next, we examined whether downregulation of Pdgfra is the
mechanism by which miR-130a regulates endothelial lineages.
Antibody-mediated inhibition of Pdgfra signaling resulted in a
significant induction of CD31 and Tie2 transcripts with no effect
on CD45 transcripts (Figures 3E–3G). Similarly, FACS analysis
showed that blocking Pdgfra signaling led to a significant in-Cecrease (2-fold) in the endothelial lineage (Tie2+/CD31+ cells)
with no effect on the hematopoietic lineage (Figures 3H–3K). To
validate these findings, we generated a Dox-inducible lentiviral
vector expressing Pdgfra (Pdgfra-IRES-GFP). In contrast to
the inhibition studies, Dox-mediated overexpression of Pdgfra
repressed the endothelial program (Tie2+/CD31+ cells) from
6.90% ± 1.5% to 2.5%± 0.75%without affecting the hematopoi-
etic lineage (Figures 3L–3O). To further investigate the interaction
between miR-130a and Pdgfra signaling, we engineered an
inducible Pdgfra mouse ESC line using miR-130a iESCs, which
overexpressed both miR-130a and Pdgfra in response to Dox
(miR-130a+Pdgfra-IRES-GFP iESC) (Figure S3I). As expected,
induction of miR-130a alone resulted in an induction of the endo-
thelial lineage. Forced overexpression of miR-130a and Pdgfra
resulted in a significant reduction (2.5-fold) of Tie2+/CD31+ cells
with no effect on the hematopoietic populations (Figures S3J–
S3M). These results demonstrated that miR-130a regulates the
endothelial lineage via downregulation of Pdgfra signaling.
miR-130a Modulates Flk1+/Pdgfra+ Mesodermal
Progenitors toward Lateral Plate Mesodermal Lineage
Our results above demonstrated that miR-130a regulates the dif-
ferentiation of the endothelial lineage in vivo. We next examined
whether miR-130a has a role during the mesodermal specifica-
tion stage. Studies have shown that Flk1/Pdgfra+ (paraxial
mesoderm) and Flk1+/Pdgfra (lateral plate mesoderm) cells
arise from the Flk1+/Pdgfra+ (unpatterned mesoderm) by modu-
lating Pdgfra levels at early stages of ESC/EB differentiation (Ka-
taoka et al., 2011; Sakurai et al., 2006). Therefore, we performed
a shorter pulse (48 hr) and examined whether miR-130a pro-
moted the endothelial lineage from mesodermal progenitors. A
48-hr Dox pulse between days 2 and 4 using miR-130a iESCs/
EBs resulted in a markedly reduced percentage (54% ± 4% to
35% ± 2%) of the Flk1/Pdgfra+, but not Flk1+/Pdgfra+ popula-
tions (Figures 4A–4C). qPCR analyses showed reduction of
Pdgfra transcripts in Dox-pulsed miR-130a EBs, confirming
that miR-130a targets PdgframRNA (Figure 4D). Notably, similar
to a long pulse (days 2–6) of miR-130a (Figure 2), a shorter pulse
(days 2–4) resulted in an equivalent promotion of the endothelial
lineage (Figures 4E and 4F).
We next performed aggregation-reaggregation assays to test
the ability of miR-130a to modulate mesodermal precursors.
Uninduced FACS-sorted Flk1+/Pdgfra and Flk1+/Pdgfra+ cells
from miR-130a iESCs/EBs (day 3.5) were reaggregated for an
additional 48 hr in the absence or presence of Dox and were
analyzed for mesodermal derivatives at day 6 using cell-surface
markers (Figure 4G). We did not detect significant differences in
the number of endothelial cells derived from the Flk1+/Pdgfra
population, demonstrating that overexpression of miR-130a
did not influence the fate of lineage-committed endothelial
populations (data not shown). FACS analyses of Flk1+/Pdgfra+
reaggregates revealed an emergence of the endothelial lineages
(Figure 4H), supporting the existence of early unpatterned
mesodermal cells within this population (Sakurai et al., 2006).
Importantly, a Dox pulse (days 4–6) in the double-positive
reaggregates resulted in a significant increase (12% ± 3% to
22% ± 2%) of endothelial cells (Figures 4H and 4I). In contrast,
the blood colony-forming activity from either Flk1+/Pdgfra orll Reports 13, 915–923, November 3, 2015 ª2015 The Authors 919
Figure 3. miR-130a Targets Pdgfra and
miR-130a-Pdgfra Pathway Modulates Meso-
dermal Progenitors
(A) ClustalW multiple sequence alignment of Pdgfra
30 UTR and miR-130a.
(B) Luciferase activity of Luc-Pdgfra-30-UTR re-
porter constructs in the presence of miR-130a
mimic and miR-130a antagomir.
(C) Whole-mount in situ hybridization images of
control and miR-130a morphants using pdgfra
probes at 48 hpf.
(D) qPCR analysis of pdgfra transcripts using fli1-
EGFP+-sorted cells from control and miR-130a
morphants at 48 hpf.
(E–G) qPCR analysis of CD31, Tie2, and CD45
transcripts from control and Pdgfra neutralizing-
antibody-treated EBs.
(H–K) Representative FACS profile (H and J) and
quantification (I and K) of endothelial lineages (H
and I) and hematopoietic lineages (J and K) in con-
trol and Pdgfra neutralizing-antibody-treated EBs.
(L–O) Representative FACS profile (L and N) and
quantification (M and O) of endothelial lineages
(L and M) and hematopoietic lineages (N and O)
using day 6 EBs in control and Pdgfra-over-
expression conditions.
Error bars indicate SEM (n = 5; *p < 0.05). Scale bar,
200 mm (see also Figure S3).
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Figure 4. miR-130a Targets Pdgfra In Vivo
and Promotes Lateral Plate Mesodermal
Lineage
(A–C) FACS profile (A) and quantification (B and C)
of mesodermal populations in miR-130a iESC/EB
differentiation in Dox and +Dox conditions.
(D) qPCR analysis of Pdgfra in -Dox and +Dox
conditions using day 4 EBs.
(E and F) FACS profile and quantification (F) of
endothelial (Flk1 and CD31) markers during miR-
130a iESC/EB differentiation in Dox and +Dox
conditions.
(G) Schematic of the experiment to determine the
ability of miR-130a to re-specify mesoderm.
(H and I) FACS profiles (H) and quantification (I) of
endothelial markers at day 6.
(J and K) Hematopoietic colony forming assay
from Flk1+/Pdgfra (J) and Flk+/Pdgfra+ (K) sorted
cells using day 3.5 miR-130a iESC/EB system.
Error bars indicate SEM (n = 3; *p < 0.05).Flk1+/Pdgfra+ cell populations did not show significant changes
(Figures 4J and 4K), demonstrating that the effect of miR-130a is
specific to the promotion of the endothelial lineage. These data
indicated that miR-130a directed the unpatterned mesodermal
lineage toward lateral plate mesoderm by suppression of Pdgfra
expression.
DISCUSSION
Here, we defined the essential role of the Etv2-miR-130a-Pdgfra
network in the divergence of hemato-endothelial progenitors.
Mechanistically, miR-130a promotes endothelial lineage devel-Cell Reports 13, 915–923,opment by modulating Pdgfra signaling.
Together, we have uncovered an impor-
tant role for a miRNA in the specific pro-
motion of the endothelial lineage without
affecting the hematopoietic lineage.
miRNAs are known to be an important
regulator of transcript expression; how-
ever, only a limited number of miRNAs
have specific developmental roles. For
example, the miR-430/427/302 family
controls mesendodermal fate specifica-
tion, and miR-1/miR-133 (muscle-spe-
cific miRNAs) can promote mesodermal
formation during embryogenesis (Ivey
et al., 2008; Rosa et al., 2009). Our study
reports a functional role for miR-130a
that specifically promotes differentiation
of the endothelial lineage.
Previous reports suggest that Etv2
is essential for the progression of Flk1+/
Pdgfra+ progenitors (primitive meso-
derm) to the Flk1+/Pdgfra (vascular
mesoderm) state (Kataoka et al., 2011).
Based on our observations, we propose
that the Etv2-miR-130a cascade downre-gulates Pdgfra expression and promotes the transition of Flk1+/
Pdgfra+ to the Flk1+/Pdgfra lineages. We further propose that
miR-130a facilitates the segregation of bipotent progenitors
toward the endothelial lineage without affecting the hematopoi-
etic lineage.
Since mutation of Etv2 affects both hematopoietic and endo-
thelial lineages (Koyano-Nakagawa et al., 2012), it was unex-
pected to discover that miR-130a targets Pdgfra and promotes
only the endothelial lineage. However, these results are sup-
ported by the finding that fetal liver hematopoiesis was not
affected in the Pdgfra conditional knockout embryos (Ding
et al., 2013). Our data, together with others (Ding et al., 2013),November 3, 2015 ª2015 The Authors 921
support the notion that the endothelial lineage, but not the he-
matopoietic lineage, is sensitive to the level of Pdgfra. We pro-
pose that as Flk1+/Pdgfra+ common mesodermal progenitors
progress to the Flk1+/Pdgfra hemato-endothelial progenitors,
miR-130a further downregulatesPdgfra expression to direct cells
toward the endothelial lineage (Figure S4). This is in agreement
with a previous report highlighting that newly generated Flk1 sin-
gle-positive cells are still plastic in nature and could switch be-
tween the Pdgfra single-positive state and Flk1 single-positive
cells spontaneously before lineage commitment (Sakurai et al.,
2006). We propose that the Etv2-miR-130a-Pdgfra pathway
may function to stabilize this plastic intermediate state toward
an endothelial fate by suppressing the fluctuating levels of Pdgfra.
Despite several reports emphasizing the existence of a common
progenitor for endothelial, cardiac, and smooth muscle lineages
(Kattman et al., 2006; Moretti et al., 2006), it is unclear whether
Flk1+/Pdgfra+ (unpatternedmesoderm) cells have equivalent car-
diacandvascularpotential. Therefore, it ispossible thatmiR-130a
induces the endothelial program by promoting a pre-specified
lineage from a heterogeneous mix of cells. Our findings, together
with others, illustrate the critical role of signaling pathways, tran-
scription factors and miRNAs in the regulation of cell fate deci-
sions, thereby forming an integral part of the regulatory network
in the emergence of mesodermal lineages. While several factors
including HoxA3, Runx1, Notch1, Sox17, and miR-142-3p have
been shown to have a critical role in hematopoietic lineage
segregation and hemangioblast specification (Iacovino et al.,
2011; Nimmo et al., 2013; Lizama et al., 2015), endothelial-
specific regulators have not been described. In summary, miR-
130a is an important regulator of endothelial development from
the hemato-endothelial progenitors (Figure S4).
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in Supplemental Experimental
Procedures.
Generation of Dicer Conditional Null Mice and Morphological
Analysis
All animal studies were approved by the Institutional Animal Care and Use
Committee at the University of Minnesota. DicerL/L mice (strain: B6.Cg-
Dicertm1Bdh/J) (Harfe et al., 2005) were intercrossed with Mesp1-Cre (Saga
et al., 1999), Flk1-Cre (Shalaby et al., 1995), and Etv2-Cre (Rasmussen et al.,
2011) mice to generate Mesp1-Cre;DicerL/+, Flk1-Cre;DicerL/+, and Etv2-
Cre;DicerL/+ mice and subsequently crossed with DicerL/L mice to generate
conditional Dicer knockouts.
Generation of the Inducible miR-130a Mouse ESC Line, Inducible
Pdgfra ESC Lines, ESC/EB Culture Conditions, and FACS Analysis
ESC culture conditions, ESC/EB differentiation, and the generation of the Dox-
inducible miR-130a ESCs were performed as previously reported (Iacovino
et al., 2011).
Generation of miR130a/ ESCs
Targeted deletion of miR-130a locus was achieved using CRISPR/Cas9 tech-
nology. For a detailed description, please see Supplemental Experimental
Procedures.
Statistical Analysis
All experiments were repeated at least three times, and the data represent
the mean ± SEM. Statistical significance was determined using the Student’s
t test, and a p value% 0.05 was considered as a significant change.922 Cell Reports 13, 915–923, November 3, 2015 ª2015 The AuthorsSupplemental information
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.09.060.
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